Description

Ozoralizumab is a biopharmaceutical compound, specifically a humanized anti-TNFα NANOBODY® conjugate, designed for targeted therapeutic intervention. Its primary value lies in its unique mechanism of action, offering high specificity and affinity for modulating inflammatory pathways. This product is essential for pharmaceutical research and development, particularly in the creation of advanced biologic therapies for autoimmune and inflammatory diseases. It serves as a critical intermediate or active pharmaceutical ingredient for manufacturers developing next-generation treatments.

Application

• Primary Active Pharmaceutical Ingredient (API) in biologic drug formulations.
• Key intermediate in the research and development of novel anti-inflammatory therapeutics.
• Reference standard for analytical method development and quality control in biopharmaceutical manufacturing.
• Critical material for preclinical and clinical studies targeting autoimmune disorders such as rheumatoid arthritis.
• Component in the development of targeted drug delivery systems and conjugate therapies.
• Tool compound for investigating TNFα-mediated signaling pathways in academic and industrial research.

Basic Information

Item	Detail
Product Name	Ozoralizumab
CAS No.	1167985-17-2
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	ATN-103; Ozoralizumab (INN); Anti-TNFα NANOBODY® Conjugate; Humanized Anti-TNFα VHH Albumin Fusion Protein; TNFα Inhibitor Nanobody; Nanobody-TNFα Conjugate
EINECS	Contact for details

Quality Control

Our Ozoralizumab is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity, mass spectrometry for identity confirmation, and biological activity assays, to ensure it meets the high standards required for pharmaceutical development. Certificates of Analysis (COA) documenting full specifications are provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below for long-term stability. This product is hygroscopic (moisture-sensitive) and should be handled under controlled, dry conditions to maintain integrity. Allow the container to reach room temperature before opening to prevent condensation.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (Mass Spec)	Conforms
Purity (HPLC)	≥ 95.0%
Biological Activity (Binding Assay)	Conforms
Endotoxin	< 1.0 EU/mg
Residual Moisture (KF)	< 5.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.